NCT03827941Recruiting
Auricular Transcutaneous Electrical Nerve Stimulation Treatment of Autism
Source: ClinicalTrials.gov · Last updated 17 Jul 2026
Brief summary (registry, in English)
In this study, investigators will examine the treatment effects of transcutaneous electrical nerve stimulation with different stimulation frequencies on individuals with autism.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 28 Jan 2019
- Start date
- 1 Nov 2022
- Primary completion date
- 28 Sept 2027
- Lead sponsor
- Massachusetts General Hospital
- Diseases
- Autism
- NCT number
- NCT03827941
What you commit to
- Study type: Interventional
- Planned participants: 40
- From 1 Nov 2022 to the primary completion date, 28 Sept 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Subjects taking any medications that confound the study results
Other illness
- A history of chronic serious infection, any current infection, any type of cancer or autoimmune disease or other severe diseases;
Who the study is looking for
- Autism diagnosed based on DSM-V classification criteria
- 18-60 year old high functioning adult autism patients (e.g. Asperger's, IQ equal or greater than 80)
- Subjects who do not show aggressive behaviors based on neuro/psychiatric evaluations as determined by a licensed study physician.
Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| MGB Coordinator of this site? Confirm its status | Charlestown | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.